Related Experiment Video
Updated: Jul 9, 2025

Assessing Microglial Phagocytosis of Myelin Debris in vitro Under Repeated Magnetic Stimulation
Published on: June 17, 2025
Transient Receptor Potential Vanilloid 4-Dependent Microglial Function in Myelin Injury and Repair
Jameson P Holloman1, Sophia H Dimas2, Angela S Archambault1
1Department of Neurology, Washington University School of Medicine, Saint Louis, MO 63110, USA.
Transient receptor potential vanilloid 4 (TRPV4) deletion enhances microglial phagocytosis but does not affect multiple sclerosis (MS) disease severity or demyelination in mouse models. TRPV4 appears to have a limited role in MS pathogenesis.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Neuroscience
Background:
- Microglia play dual roles in multiple sclerosis (MS) pathogenesis, contributing to both inflammation and neuroprotection.
- Transient receptor potential vanilloid 4 (TRPV4) channels are involved in cellular sensing, calcium homeostasis, and modulate myeloid cell functions.
- TRPV4 influences microglial motility and phagocytosis, suggesting a potential role in MS.
Purpose of the Study:
- To investigate the role of TRPV4 in microglial phagocytosis and its impact on demyelination and disease activity in MS models.
- To determine if genetic deletion of TRPV4 affects disease progression in experimental autoimmune encephalitis (EAE) and cuprizone-induced demyelination models.
- To assess TRPV4 expression in MS brain tissue.
Main Methods:
- In vitro assessment of microglial phagocytosis following TRPV4 deletion.
- Evaluation of demyelination and remyelination in the cuprizone mouse model with TRPV4 deletion.
- Assessment of disease severity in the EAE model with global and microglia-specific TRPV4 deletion.
- Analysis of TRPV4 expression in human MS brain tissue.
Main Results:
- Genetic deletion of TRPV4 increased microglial phagocytosis in vitro.
- TRPV4 deletion did not alter demyelination or remyelination in the cuprizone model.
- No significant differences in disease severity were observed in EAE models with TRPV4 deletion.
- TRPV4 expression levels were similar in lesioned, normal-appearing white matter, and healthy brain tissue from MS patients.
Conclusions:
- TRPV4 modulates microglial phagocytic activity in vitro.
- TRPV4 does not significantly impact disease activity or demyelination in experimental models of MS.
- These findings suggest a muted or redundant role for TRPV4 in the pathogenesis of MS.
More Related Videos
10:21Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019